Categories: Invest

Should I buy IBM shares after Q4 results?

International Business Machines Corporation (NYSE: IBM) will announce fourth-quarter earnings results this Monday, January 24, after the market closes.

IBM shares have weakened slightly above 3% since the beginning of 2022 year, and the current price stands at $129.35.

UBS downgraded IBM


Are you looking for fast-news, hot-tips and market analysis?

Sign-up for the Invezz newsletter, today.

IBM will announce fourth-quarter earnings results this Monday; the consensus earnings per share estimate stands at $3.29 (+58.9% Y/Y), while the consensus revenue estimate is $15.98 billion (-21.6% Y/Y).

Over the last two years, IBM has beaten earning per share estimate every time; still, the company has beaten revenue estimates 63% of the time.

The company’s shares have weakened after IBM reported third-quarter results in October, which showed that IBM earned $2.52 a share on revenue of $17.62 billion and missed analyst estimates by $190 million.

The disappointing sales results were mainly connected with IBM’s global technology services business, but the board of directors said that expects double-digit revenue growth in IBM consulting division for the fourth quarter and software revenue growth rate to improve versus the third quarter.

IBM recently announced plans to sell off its healthcare data and analytics assets to Francisco Partners, and it is important to mention that IBM completed the spinoff of its managed technology services business, Kyndryl (NYSE: KD).

Negative information is that UBS downgraded IBM and assigned a “sell” rating after the Kyndryl spinoff, citing an “elevated valuation that leaves the shares vulnerable over the next twelve months. Analyst David Vogt lowered his price target to $124 and added:

The market is pricing in 2022 and 2023 earnings estimates that are 10% higher than my estimate, and the IBM stock has benefited from a rotation from growth to value, which creates risk.

Despite this, IMB has a strong position in the market; the company continues to pay an attractive dividend and ​improve its business for long-term growth and advantage.

The current dividend yield stands around 5%, IBM trades at less than eight times TTM EBITDA, and this company could deliver substantial shareholder value for many years to come.

Technical analysis

International Business Machines Corporation (IBM) shares weakened slightly above 3% since the beginning of the 2022 year, but if the company posts strong fourth-quarter earnings results, the share price could be above the current levels.

Data source: tradingview.com

If the price jumps above $135, it will signal to buy IBM shares, and the next target could be $140.

On the other side, if the price falls below $125 support, it would be a “sell” signal, and we have the open way to $120.

Summary

IBM will announce fourth-quarter earnings results this Monday, and if the company posts strong fourth-quarter earnings results, the share price could be above the current levels. IBM could deliver substantial shareholder value for many years to come, but UBS downgraded IBM and assigned a “sell” rating after the Kyndryl spinoff.

Where to buy right now

To invest simply and easily, users need a low-fee broker with a track record of reliability. The following brokers are highly rated, recognised worldwide, and safe to use:

  1. Etoro, trusted by over 13m users worldwide. Register here >
  2. bitFlyer, simple, easy to use and regulated. Register here >
admin

Share
Published by
admin

Recent Posts

Is there a way for the crypto sector to avoid Bitcoin’s halving-related bear markets?

There is good reason to be afraid. Previous down markets have seen declines in excess…

2 years ago

UPS and FedEx are good dividend stocks, but which should you take?

United Parcel Service, Inc. (NYSE:UPS) and FedEx Corporation (NYSE:FDX) are two robust logistics companies. Both…

2 years ago

Bitfarms sold 3K Bitcoin as part of strategy to improve liquidity and pay debts

Canadian crypto mining firm Bitfarms sold roughly $62 million worth of Bitcoin (BTC) in June,…

2 years ago

This biotech stock is up 100% on Tuesday: here’s the catalyst

Invezz does not provide financial advice. Our aim is to simplify information about investing, enabling…

2 years ago

Japanese film studio announces the production of a series based on crypto

Noma, a Japanese film studio, has announced that it is producing three feature films that…

2 years ago

Bitcoin price taps 5-day highs as Shiba Inu leads altcoin gains

Bitcoin (BTC) saw continued strength on June 21 as Wall Street trading opened with a…

2 years ago